Global DNA Sequencing Equipment and Service Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global DNA Sequencing Equipment and Service Market Research Report 2024
Gene sequencing is a new type of gene detection technology that can analyze and determine the complete sequence of genes from blood or saliva, predict the possibility of suffering from a variety of diseases, and individual behavior characteristics and behaviors are reasonable. Gene sequencing technology can lock individual disease genes, prevent and treat them in advance. Gene sequencing-related products and technologies have evolved from laboratory research to clinical use. It can be said that gene sequencing technology is the next technology that will change the world.
According to MRAResearch’s new survey, global DNA Sequencing Equipment and Service market is projected to reach US$ 3633.9 million in 2033, increasing from US$ 2044 million in 2022, with the CAGR of 9.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole DNA Sequencing Equipment and Service market research.
Key companies engaged in the DNA Sequencing Equipment and Service industry include Illumina, Thermo Fisher Scientific, Eurofins Scientific, BGI, Natera, Berry, Roche, Novogene and MGI-tech, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of DNA Sequencing Equipment and Service were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole DNA Sequencing Equipment and Service market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global DNA Sequencing Equipment and Service market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Illumina
Thermo Fisher Scientific
Eurofins Scientific
BGI
Natera
Berry
Roche
Novogene
MGI-tech
LabCorp
Pacific Biosciences
Azenta Life Sciences
Oxford Nanopore
Macrogen
Segment by Type
Second-generation Sequencing
Third and Fourth Generation Sequencing
First-generation Sequencing
Academic Research
Clinical Research
Hospital Clinic
Pharmaceutical and Biotechnology
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The DNA Sequencing Equipment and Service report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global DNA Sequencing Equipment and Service market is projected to reach US$ 3633.9 million in 2033, increasing from US$ 2044 million in 2022, with the CAGR of 9.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole DNA Sequencing Equipment and Service market research.
Key companies engaged in the DNA Sequencing Equipment and Service industry include Illumina, Thermo Fisher Scientific, Eurofins Scientific, BGI, Natera, Berry, Roche, Novogene and MGI-tech, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of DNA Sequencing Equipment and Service were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole DNA Sequencing Equipment and Service market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global DNA Sequencing Equipment and Service market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Illumina
Thermo Fisher Scientific
Eurofins Scientific
BGI
Natera
Berry
Roche
Novogene
MGI-tech
LabCorp
Pacific Biosciences
Azenta Life Sciences
Oxford Nanopore
Macrogen
Segment by Type
Second-generation Sequencing
Third and Fourth Generation Sequencing
First-generation Sequencing
Segment by Application
Academic Research
Clinical Research
Hospital Clinic
Pharmaceutical and Biotechnology
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The DNA Sequencing Equipment and Service report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source